Keith Scarfo, DO
Anesthesiology · Providence, RINPI 1003012014
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (43.2%), consulting fees and education — rather than concentrated in one kind of arrangement. Abbott accounts for 62.7% of it on its own, with 2 other manufacturers making up the rest. Among anesthesiology clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $222.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Vertiflex, Inc.$2K
- Electronic Waveform Lab, Inc.$44
Across 33 payments — averaging $6291.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$208K
What the payments were for
- Consulting fees$1,10025%
- Travel & lodging$1,92043%
- Food & beverage$46911%
- Education$95521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 11 | $2,789 |
| Vertiflex, Inc. | 7 | $1,612 |
| Electronic Waveform Lab, Inc. | 2 | $44 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$1,773
- Superion ISS$1,443
- Proclaim IPG$891
How this compares
$4,445 in reported general payments places this provider in the 95th percentile of 122 anesthesiology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 388 | $4,622 |
| Pregabalin | 112 | $1,087 |
| Duloxetine Hcl | 70 | $841 |
| Methylprednisolone | 83 | $739 |
| Baclofen | 37 | $636 |
| Tizanidine Hcl | 27 | $421 |
| Meloxicam | 68 | $399 |
| Tramadol Hcl | 16 | $52 |
| Methocarbamol | 12 | $29 |
| Diazepam | 12 | $16 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Providence
- Harish LecamwasamProvidence$436K
- William YelleProvidence$5K
- Andrew MaslowProvidence$5K
- Derek KellerProvidence$1K
- Ann Marie Gonzalez MunozProvidence$1K
- Nina JiProvidence$1K
- Marina GarasProvidence$1K
- Colin FoleyProvidence$774
- Scott MackinnonProvidence$690
- Rabia AmirProvidence$565
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.